Skip to content

Author

Farheen Siddiqui

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Therapeutic Boon or Hidden Bane? Semaglutide for Weight Loss in Non-diabetics

Semaglutide, a long-acting GLP-1 receptor agonist indicated for type 2 diabetes, has recently been approved by the US FDA for chronic weight management in non-diabetic obese patients. It works on GLP-1 receptors in the gut, pancreas, and hypothalamus to stimulate insulin release, decelerate stomach emptying, and augmen...

A. K. Sangtiani, Iqra Qamar, Hassan Shamim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.